Vinci Mirella, Musumeci Antonino, Papa Carla, Ragalmuto Alda, Saccone Salvatore, Federico Concetta, Greco Donatella, Greco Vittoria, Calì Francesco, Treccarichi Simone
Oasi Research Institute-IRCCS, 94018 Troina, Italy.
Department Biological, Geological and Environmental Sciences, University of Catania, Via Androne 81, 95124 Catania, Italy.
Int J Mol Sci. 2025 Jul 2;26(13):6386. doi: 10.3390/ijms26136386.
The 26S proteasome is a large, ATP-dependent proteolytic complex responsible for degrading ubiquitinated proteins in eukaryotic cells. It plays a crucial role in maintaining cellular protein homeostasis by selectively eliminating misfolded, damaged, or regulatory proteins marked for degradation. In this study, whole-exome sequencing (WES) was performed on an individual presenting with developmental delay and mild intellectual disability, as well as on both of his unaffected parents. This analysis identified a de novo variant, c.959C>G (p.Pro320Arg), in the gene. As predicted, this gene shows a very likely autosomal dominant inheritance pattern. Notably, has not previously been associated with any phenotype in the OMIM database. This variant was recently submitted to the ClinVar database as a variant of uncertain significance (VUS) and remains absent in both gnomAD and dbSNP. Notably, it has been identified in six unrelated individuals presenting with clinical features comparable to those observed in the patient described in this study. Multiple in silico prediction tools classified the variant as pathogenic, and a PhyloP conservation score supports strong evolutionary conservation of the mutated nucleotide. Protein structure predictions using the AlphaFold3 algorithm revealed notable structural differences between the mutant and wild-type PSMC5 proteins. We hypothesize that the p.Pro320Arg substitution alters the structure and function of PSMC5 as a regulatory subunit of the 26S proteasome, potentially impairing the stability and activity of the entire complex. Although functional studies are imperative, this study contributes to a deeper understanding of , expands the spectrum of associated neurodevelopmental phenotypes, and highlights its potential as a therapeutic target. Furthermore, this study resulted in the submission of the identified variant to the ClinVar database (SCV006083352), where it was classified as pathogenic.
26S蛋白酶体是一种大型的、依赖ATP的蛋白水解复合物,负责在真核细胞中降解泛素化蛋白。它通过选择性地清除被标记用于降解的错误折叠、受损或调节蛋白,在维持细胞蛋白质稳态中发挥关键作用。在本研究中,对一名患有发育迟缓及轻度智力障碍的个体及其未受影响的双亲进行了全外显子测序(WES)。该分析在 基因中鉴定出一个新生变异,c.959C>G(p.Pro320Arg)。正如所预测的,该基因显示出非常可能的常染色体显性遗传模式。值得注意的是, 此前在OMIM数据库中未与任何表型相关联。这个变异最近作为意义未明的变异(VUS)提交到ClinVar数据库,并且在gnomAD和dbSNP中均未出现。值得注意的是,在另外6名具有与本研究中所描述患者类似临床特征的无关个体中也发现了该变异。多种计算机预测工具将该变异分类为致病性变异,并且一个PhyloP保守性评分支持突变核苷酸的强烈进化保守性。使用AlphaFold3算法进行的蛋白质结构预测揭示了突变型和野生型PSMC5蛋白之间显著的结构差异。我们推测p.Pro320Arg替换改变了作为26S蛋白酶体调节亚基的PSMC5的结构和功能,可能损害整个复合物的稳定性和活性。尽管功能研究势在必行,但本研究有助于更深入地了解 ,扩展相关神经发育表型的范围,并突出其作为治疗靶点的潜力。此外,本研究导致将鉴定出的变异提交到ClinVar数据库(SCV006083352),在那里它被分类为致病性变异。